1. Home
  2. AMBO vs GTBP Comparison

AMBO vs GTBP Comparison

Compare AMBO & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMBO
  • GTBP
  • Stock Information
  • Founded
  • AMBO 2000
  • GTBP 1965
  • Country
  • AMBO United States
  • GTBP United States
  • Employees
  • AMBO N/A
  • GTBP N/A
  • Industry
  • AMBO Other Consumer Services
  • GTBP Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMBO Real Estate
  • GTBP Health Care
  • Exchange
  • AMBO Nasdaq
  • GTBP Nasdaq
  • Market Cap
  • AMBO 7.0M
  • GTBP 5.5M
  • IPO Year
  • AMBO 2010
  • GTBP N/A
  • Fundamental
  • Price
  • AMBO $2.71
  • GTBP $2.14
  • Analyst Decision
  • AMBO
  • GTBP Strong Buy
  • Analyst Count
  • AMBO 0
  • GTBP 1
  • Target Price
  • AMBO N/A
  • GTBP $11.00
  • AVG Volume (30 Days)
  • AMBO 11.6K
  • GTBP 108.5K
  • Earning Date
  • AMBO 01-01-0001
  • GTBP 08-13-2025
  • Dividend Yield
  • AMBO N/A
  • GTBP N/A
  • EPS Growth
  • AMBO N/A
  • GTBP N/A
  • EPS
  • AMBO 0.11
  • GTBP N/A
  • Revenue
  • AMBO $9,392,000.00
  • GTBP N/A
  • Revenue This Year
  • AMBO N/A
  • GTBP N/A
  • Revenue Next Year
  • AMBO N/A
  • GTBP N/A
  • P/E Ratio
  • AMBO $27.31
  • GTBP N/A
  • Revenue Growth
  • AMBO 2.50
  • GTBP N/A
  • 52 Week Low
  • AMBO $1.00
  • GTBP $1.72
  • 52 Week High
  • AMBO $5.55
  • GTBP $4.10
  • Technical
  • Relative Strength Index (RSI)
  • AMBO 51.36
  • GTBP 38.82
  • Support Level
  • AMBO $2.25
  • GTBP $1.91
  • Resistance Level
  • AMBO $3.25
  • GTBP $3.73
  • Average True Range (ATR)
  • AMBO 0.29
  • GTBP 0.33
  • MACD
  • AMBO 0.06
  • GTBP -0.16
  • Stochastic Oscillator
  • AMBO 48.57
  • GTBP 19.59

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

Share on Social Networks: